GEO-CM04S1 Demonstrates Durable T Cell and Antibody Responses in Healthy and Immunocompromised Populations ...

Our body's own defense system not only clears away bacteria and viruses, it can also fight cancer. However, not all tumor ...

Antibodies are best known for their ability to latch onto and neutralize bacteria, viruses and other pathogens. But these ...

South Korea-based DAAN Biotherapeutics has entered a licensing agreement with GC Cell, granting the latter exclusive rights ...

G protein-coupled receptors (GPCRs) are involved in many diseases, yet raising therapeutic antibodies against them is notoriously difficult because the transmembrane receptors contain only short ...

Scientists discovered a gut enzyme that can convert A, B, and AB blood into universal Type O—revolutionizing transfusions and ...

The company plans to expand its manufacturing and R&D operations in its diagnostics transfusion business in Lake County, ...

People with type O blood enjoy a slightly lower risk of heart disease and blood clotting, but they may be more susceptible to hemorrhaging or bleeding disorders. This may be especially true after ...

A recent study found two patients with a novel mutation in the RHCE gene, which codes for several antigens found on red blood cells.

The team created a novel tick antigen library housing over 3,000 different proteins, testing each to create a target cocktail ...

AI is enabling the development of a next generation of drugs that can more precisely target cancer cells while sparing ...

offering a dual-targeting strategy to enhance the therapeutic efficacy of monoclonal antibodies, which is often limited by tumor heterogeneity and the occurrence of resistance mechanisms. By ...